Lovelace Biomedical Research Institute
90% goes to programs $0 to raise $100 Strong reserves
Lovelace Biomedical Research Institute is a 501(c)(3) organization based in Albuquerque, New Mexico, registered in 1969, with $91,209,797 in FY2023 revenue. CharityIndex grades it A, and it directs about 90% of spending to programs.
2425 Ridgecrest Dr Se, Albuquerque, NM, 87108 EIN 85-0110669 Since 1969
Revenue (FY2023)
$91.2M
▼ 18.7% vs prior year
Medical Research median: $217K
Expenses (FY2023)
$91.5M
Net assets
$212.0M
Employees
531
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
A
AProgram efficiency40% of the rating90% to programs · $0 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Lovelace Biomedical Research Institute: 90% to programs · $0 to raise $100 earns a A on this criterion. See the exact thresholds →
AFinancial health25% of the rating28 mo reserves · -0% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Lovelace Biomedical Research Institute: 28 mo reserves · -0% margin earns a A on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Lovelace Biomedical Research Institute: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
ATransparency10% of the rating4 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Lovelace Biomedical Research Institute: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
The lovelace biomedical research institute (lbri) is a private, biomedical research organization dedicated to improving public health through research on the prevention, treatment and cure of diseases. lbri is committed to curing diseases through research aimed at understanding their causes and biological mechanisms; assessing and eliminating exposures to respiratory, neurological and other health hazards; and developing improved therapeutics, vaccines, and diagnostics. lbri is based in albuquerque, new mexico.
Contact & location
- Address
- 2425 Ridgecrest Dr Se, Albuquerque, NM, 87108
- City
- Albuquerque
- State
- New Mexico
- Category
- Medical Research
- Subcategory
- Medical Specialty Research
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $10.5M (FY2016) to $91.2M (FY2023) across 7 reported years.
Financial snapshot
Financial health & position (FY2023)
Liabilities $44.4MNet assets $212.0M
Operating margin
-0.3%
Spent more than it raised in the latest fiscal year.
Total assets
$256.4M
Total liabilities
$44.4M
Net assets
$212.0M
Salaries & benefits
$36.9M
40% of expenses
Board members
10
6 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $91,209,797▼18.7% | $91,486,502▼3.4% | $212,022,844▲2.3% | $256,421,032▼1.1% | 990 |
| 2022 | $112,131,523▲56.8% | $94,680,185▲43.0% | $207,334,520▲71.9% | $259,201,284▲40.3% | 990 |
| 2021 | $71,507,956▼19.9% | $66,188,457▼17.6% | $120,606,119▼6.7% | $184,740,544▼2.5% | 990 |
| 2020 | $89,255,628▲16.8% | $80,362,730▲8.3% | $129,294,967▲16.8% | $189,542,168▲18.8% | 990 |
| 2019 | $76,388,415▲336% | $74,188,991▲364% | $110,727,486▲264% | $159,558,180▲156% | 990 |
| 2017 | $17,520,714▲66.2% | $15,989,123▼22.2% | $30,404,585▲4.7% | $62,218,262▲0.8% | 990 |
| 2016 | $10,540,044 | $20,559,896▼46.3% | $29,052,005▼70.4% | $61,729,283▼51.5% | 990 |
| 2012 | — | $38,265,599▼23.0% | $98,232,773▲4.5% | $127,405,466▲2.3% | 990 |
| 2011 | — | $49,699,380▲12.1% | $93,968,711▲14.0% | $124,569,232▲9.4% | 990 |
| 2010 | — | $44,352,653▲117% | $82,405,891▲16.6% | $113,814,013▲19.6% | 990 |
| 2009 | — | $20,455,248 | $70,692,180 | $95,150,604 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2023)
Highest-paid: Robert W Rubin Phd — $874,428 (0.96% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Robert W Rubin Phd | Ceo, Advisory Non-voting Director | 38 | $874,428 |
| Shannon L Toma | Treasurer, Exec Vp, Coo, Cfo | 40 | $713,675 |
| Steven A Belinsky | Vp Academic Research/sr Scientist | 40 | $404,462 |
| Kent Kiehl | Executive Science Officer | 40 | $386,988 |
| David M Flanders | Vp, Human Resources | 40 | $314,924 |
| Jacob D Mcdonald | Vp Applied Science (thru 9/7/2023) | 40 | $287,941 |
| Andrew R Mayer | Vp of Interdisciplinary Science | 40 | $282,904 |
| Edward G Barrett | Sr. Director of Pharmacology | 40 | $268,562 |
| Alan Kadish | President and Chairman of the Board | 2 | — |
| Jackie Lovelace Johnson | Chairwoman of the Board, Directors | 2 | — |
| Jane Delgado | Dir. Vice Chair Nom Committee | 2 | — |
| Jospeh D Mark | Director | 2 | — |
| Lawrence D Platt | Director | 2 | — |
| Margaret Retter | Director | 2 | — |
| Matthew F Bonilla | Special Appointee | 2 | — |
| Nicholas S Janiga | Special Appointee | 2 | — |
| Wanda Hernandez | Special Appointee | 2 | — |
| Zvigmond Ryzman | Director | 2 | — |
Top vendors & contractors (FY2023)
| Contractor | Services | Paid |
|---|---|---|
| Summit Construction Inc | Construction Services | $2,702,258 |
| Dkg and Associates Inc | Construction Services | $2,165,354 |
| Sdv Construction Inc | Construction Services | $1,463,133 |
| Universal Protection Services LP | Outsourced Security Services | $470,797 |
| Moss Adams | Accounting Services | $254,307 |
Grants received · $2.7M total
18 grants to Lovelace Biomedical Research Institute totaling $2.7M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Emory University | Research/subcontract | 2023 | $137,152 |
| American Lung Association | Research | 2022 | $200,000 |
| Emory University | Research/subcontract | 2022 | $138,601 |
| Emory University | Research/subcontract | 2021 | $117,294 |
| Emory University | Research/subcontract | 2020 | $141,700 |
| Johns Hopkins University | Sub-award | 2020 | $18,892 |
| Emory University | Research/subcontract | 2019 | $138,821 |
| Johns Hopkins University | Sub-award | 2019 | $15,735 |
| Emory University | Research/subcontract | 2018 | $95,534 |
| Johns Hopkins University | Sub-award | 2018 | $22,978 |
| Emory University | Research/subcontract | 2017 | $162,673 |
| Johns Hopkins University | Sub-award | 2017 | $14,074 |
| Emory University | Research/subcontract | 2016 | $155,813 |
| Michael J Fox Foundation For Parkinsons Research | Parkinson's research | 2015 | $1,202,543 |
| American Lung Association | Research | 2015 | $40,000 |
Similar organizations in Medical Research
Medical Research
Biomedical Research Institute of New Mexico
Albuquerque, NM
$8.2M
Bannual revenue
Medical Research
New Mexico Cancer Care Alliance
Albuquerque, NM
$2.5M
Bannual revenue
Medical Research
Society For Melanoma Research Ltd
Albuquerque, NM
$830K
Bannual revenue
Medical Research
Punching Out Parkinsons Santa Fe
Santa Fe, NM
$324K
Bannual revenue
- Medical Research
New Mexico Farm and Livestock Bureau Foundation Inc
Las Cruces, NM
$263K
C+annual revenue
Medical Research
Cowboys For Cancer Research Inc
Artesia, NM
$156K
Bannual revenue
Medical Research
Cancer Services of New Mexico
Albuquerque, NM
$150K
C+annual revenue
- Medical Research
Cancer Services of New Mexico Foundation
Albuquerque, NM
$114K
C+annual revenue
Medical Research
Taos Orthopedic Institute Research
Taos, NM
$80K
Dannual revenue
Medical Research
Highlands Stable Isotopes Corporation
Las Vegas, NM
$13K
Cannual revenue
Compare Lovelace Biomedical Research Institute
Frequently asked questions
- Is Lovelace Biomedical Research Institute a legitimate nonprofit?
- Yes. Lovelace Biomedical Research Institute is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 85-0110669, based in Albuquerque, New Mexico. Donations are tax-deductible.
- What is Lovelace Biomedical Research Institute's EIN?
- Lovelace Biomedical Research Institute's Employer Identification Number (EIN) is 85-0110669.
- How much revenue does Lovelace Biomedical Research Institute report?
- Lovelace Biomedical Research Institute reported $91,209,797 in total revenue on its fiscal year 2023 IRS Form 990 filing.
- How much of Lovelace Biomedical Research Institute's spending goes to programs?
- Lovelace Biomedical Research Institute spends about 90% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Lovelace Biomedical Research Institute have?
- CharityIndex grades Lovelace Biomedical Research Institute A, based on program efficiency and fundraising cost.
- How much does Lovelace Biomedical Research Institute's highest-paid employee make?
- The highest reported compensation on Lovelace Biomedical Research Institute's latest Form 990 is $874,428, paid to Robert W Rubin Phd (Ceo, Advisory Non-voting Director).
More nonprofits in Albuquerque
Explore more
Data for Lovelace Biomedical Research Institute (EIN 85-0110669) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.